ITEMS IN AFP WITH KEYWORD:
Mar 1, 2007 Issue
Diagnosis and Management of Chronic Heart Failure in Adults [Practice Guidelines]
Changes in the diagnosis and management of chronic heart failure in adults are reflected in updated guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA).
Feb 1, 2007 Issue
AHRQ Evaluates Peptides as Determinants for Patients with Heart Failure [Practice Guidelines]
B-type natriuretic peptide (BNP) and N-terminal pro-hormone brain natriuretic peptide (NT-proBNP) are markers for heart failure diagnosis, prognosis, and treatment. The Agency for Healthcare Research and Quality (AHRQ) systematically reviewed available literature to further study these peptides.
Brain natriuretic peptide (BNP) levels are simple and objective measures of cardiac function. These measurements can be used to diagnose heart failure, including diastolic dysfunction, and using them has been shown to save money in the emergency department setting. The high negative predictive value...
Digoxin therapy has long been used to treat heart failure; however, its effectiveness was not completely known until recently. Results of the Digitalis Investigation Group trial showed that adding digoxin to standard heart failure therapy had no effect on mortality. However, adding digoxin decreased...
Aug 1, 2006 Issue
Diuretics for Treatment of Patients with Heart Failure? [Cochrane for Clinicians]
Compared with other active medications, diuretics can improve exercise capacity in patients with heart failure by about 30 percent. Withdrawal of diuretic therapy from patients with heart failure may increase the risk of hospital readmission or death. About eight deaths are prevented for every 100 patients treated.
What are the effects of nondrug, drug and invasive treatments? What are the effects of ACE inhibitors in persons at high risk of heart failure?
Diastolic heart failure occurs when signs and symptoms of heart failure are present but left ventricular systolic function is preserved (i.e., ejection fraction greater than 45 percent). The incidence of diastolic heart failure increases with age; therefore, 50 percent of older patients with heart f...
Nesiritide improves short-term hemodynamics in hospitalized patients with acute decompensated heart failure who have not benefited from aggressive treatment with standard care. However, nesiritide may cause renal function to worsen and may increase the risk of death within 30 days.
The American Heart Association has published a science advisory on selecting patients for cardiac resynchronization therapy (CRT).
Optimal outpatient treatment of systolic heart failure has three goals that should be pursued simultaneously: (1) control of risk factors for the development and progression of heart failure, (2) treatment of heart failure, and (3) education of patients. Control of risk factors includes treating hyp...